Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of NetApp, Inc. (NASDAQ: NTAP) shares rose sharply in today’s pre-market trading after the company reported better-than-expected third-quarter financial results and issued guidance.
NetApp posted adjusted earnings of $1.94 per share, beating market estimates of $1.69 per share. The company’s quarterly sales came in at $1.610 billion, versus expectations of $1.591 billion, according to data from Benzinga Pro.
NetApp shares jumped 17.3% to $104.50 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Nxu, Inc. (NASDAQ: NXU) gained 111.4% to $1.69 in pre-market trading after the company announced it successfully charged a Tesla Cybertruck on Feb. 26.
- Minim, Inc. (NASDAQ: MINM) shares rose 36.4% to $5.87 in pre-market trading. On Feb. 20, Minim entered into an employment agreement with David Lazar to engage him as CEO, CFO, following resignation of Jeremy Hitchcock.
- Know Labs, Inc. (NYSE: KNW) gained 35.4% to $1.06 in pre-market trading after the company secured U.S. $12 million funding for company's further execution on its clinical research and development initiatives.
- Akanda Corp. (NASDAQ: AKAN) shares surged 30.1% to $0.3273 in pre-market trading. Akanda signed a definitive Share Purchase Agreement and Escrow Agreement for the sale of Portuguese assets to Somai Pharmaceuticals.
- Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) gained 23.4% to $20.62 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
- Dell Technologies Inc. (NYSE: DELL) rose 21.4% to $115.00 in pre-market trading reported better-than-expected fourth-quarter financial results and increased its annual cash dividend by 20%.
- Cardiff Oncology, Inc. (NASDAQ: CRDF) shares rose 21.3% to $2.14 in pre-market trading after the company reported better-than-expected fourth-quarter financial results, provided a clinical update on the Phase 2 randomized second-line ONSEMBLE trial in patients with RAS-mutated mCRC and announced the first patient was dosed in the randomized first-line RAS-mutated mCRC trial.
- Navitas Semiconductor Corporation (NASDAQ: NVTS) climbed 14.3% to $7.02 in pre-market trading following upbeat fourth-quarter results.
- Nutex Health Inc. (NASDAQ: NUTX) shares gained 13.3% to $0.1280 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- GigCapital5, Inc. (NASDAQ: GIA) shares dipped 64% to $3.99 in pre-market trading. GigCapital5 announced closing date of March 4, 2024 for business combination with QT Imaging.
- Fisker Inc. (NYSE: FSR) shares tumbled 38.4% to $0.4482 after the company reported preliminary fourth-quarter total revenue results below estimates and said it expects to conclude there is substantial doubt about its ability to continue as a going concern when its annual financial statements are filed with the SEC.
- Sidus Space, Inc. (NASDAQ: SIDU) fell 33.7% to $5.95 in pre-market trading. Sidus Space priced public offering 1,321,000 Class A common share at $6 per share.
- Scilex Holding Company (NASDAQ: SCLX) shares declined 32.2% to $1.54 in pre-market trading after reporting a $10 million bought deal offering.
- New York Community Bancorp, Inc. (NASDAQ: NYCB) fell 28% to $3.45 in pre-market trading after the company identified material weakness in internal controls and announced a leadership transition.
- Gritstone bio, Inc. (NASDAQ: GRTS) fell 26.1% to $2.07 pre-market trading after the company announced an approximately 40% reduction of its workforce.
- Humacyte, Inc. (NASDAQ: HUMA) shares dipped 23.5% to $3.33 in pre-market trading. Humacyte priced its $40.2 million public offering of 13.4 million common stock at $3 per share.
- SoundHound AI, Inc. (NASDAQ: SOUN) shares fell 18.8% to $6.02 in pre-market trading after the company reported weaker-than-expected fourth-quarter financial results.
- Cue Health Inc. (NASDAQ: HLTH) shares fell 16.6% to $0.2669 in pre-market trading. Cue Health has received a decision to grant European patent number EP3191849 titled "Systems and Methods for Detection and Quantification of Analytes."
- B. Riley Financial, Inc. (NASDAQ: RILY) shares declined 14.5% to $15.67 in pre-market trading after the company reported fourth-quarter financial results and announced it has launched a review of strategic alternatives for its Appraisal and Valuation Services, and Retail, Wholesale & Industrial Solutions businesses.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Now Read This: Dell, SoundHound AI And 3 Stocks To Watch Heading Into Friday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.